10-K Decoder · All companies

Aclaris Therapeutics, Inc.

ACRS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$7.83M$18.7M−58.2%
Operating income−$76.4M−$142M+46.2%
Net income−$64.9M−$132M+50.8%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$1.50M$3.30M−54.5%
Operating income−$21.3M−$17.1M−24.6%
Net income−$18.5M−$14.6M−26.7%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Aclaris's revenue in FY2025?
$7.83M in FY2025 (Fiscal year ended Dec 31, 2025), −58.2% vs $18.7M a year earlier, per its 10-K filed Feb 2026.
Was Aclaris profitable in FY2025?
No: net income was −$64.9M and operating income −$76.4M in FY2025.
What was Aclaris's revenue in Q3 2026?
$1.50M (−54.5% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.